Your browser does not support iframes.
Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Arena Pharmaceuticals, Inc.
(NQ:
ARNA
)
7.920
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Arena Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from
ACCESSWIRE
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity...
Read More
category
ETRM
,
Bio/Wire
from
Bio-Wire.Com
Post Earnings Update: Arena Pharmaceuticals Has Sunk 5.0% Lower in Past 2 Weeks (ARNA)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
A cautious DEA meets a cautiously optimistic FDA
Read More
category
TOKYO:ESALY
,
NASDAQ:OREX
,
NASDAQ:ARNA
, and 1 more.
from
Forbes Real Time
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals
May 10, 2013
Read More
category
OTCBB:ELTP
,
NASDAQ:ARNA
from
InvestorPlace - Latest Headlines
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed...
Read More
category
NASDAQ:OREX
,
NASDAQ:ARNA
,
NASDAQ:VVUS
from
Forbes Real Time
Streetinsider.com's Hot Lunchtime Reads 05/08: (DDD) (LAZ) (VCLK) (MDLZ)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317297 for the full story.
Read More
from
StreetInsider.com News Articles
VIVUS, Inc. (VVUS) Pops as Larger Qsymia Retail Presence Expected Soon
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317224 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE 2-Vivus in talks with large pharma cos for diet drug tie-up; shares rise
May 08, 2013
* Qsymia to be available in retail pharmacies from mid-July
Read More
category
companyNews
from
Reuters: Company News
JCPenney Same-Store Sales Sink: 6 Stocks in 60 Seconds
May 08, 2013
Read More
category
NYSEARCA:SPY
,
NYSE:JCP
,
NASDAQ:GRPN
, and 3 more.
from
InvestorPlace - Latest Headlines
Record Day For Dow, S&P 500
May 07, 2013
The Dow closed above the 15,000 mark for the first time by climbing 87 points to 15,056. Nasdaq rose 3 points to 3396.
Read More
category
Market News
from
MarketMinute.com Market Updates
Stocks Crossing 50-Day SMA 05/07: (PFE) (JPM) (ARNA) Above; (FTR) (GGB) (ORCL) Below
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313325 for the full story.
Read More
from
StreetInsider.com News Articles
Arena (ARNA) Confirms BELVIQ Will Soon Be Available for Sale in the U.S.
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313240 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai
May 07, 2013
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ...
Read More
category
Benzinga
,
ARNA
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Streetinsider.com's Hot Lunchtime Reads 05/07: (NOK) (GLD) (FSLR) (TSLA) (ARNA)
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8312449 for the full story.
Read More
from
StreetInsider.com News Articles
Arena (ARNA) Clears Final BELVIQ Marketing Hurdle; Could Make U.S. Debut in June
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8312432 for the full story.
Read More
from
StreetInsider.com News Articles
Belviq Is Not the Next Fen-Phen … Probably
May 07, 2013
Read More
category
Hot Stocks
,
NASDAQ:ARNA
from
InvestorPlace - Latest Headlines
Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe
May 07, 2013
Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe Responding to news that the company would withdraw its MAA (Marketing Authorization Application) for Belviq (lorcaserin) from the EMA...
Read More
category
ARNA
,
Bio/Wire
,
VVUS
from
Bio-Wire.Com
Arena Pharmaceuticals (ARNA) - Market Review
May 07, 2013
NEW YORK (AVAFIN) -- Arena Pharmaceuticals options set a new 90-day record for the ...
Read More
from
AVAFIN
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last...
Read More
category
Prime Content
,
AEGR
,
REGN
, and 5 more.
from
Bio-Wire.Com
Vivus and QSYMIA: Tailwinds but Significant Uncertainty Remains
May 06, 2013
Since peaking over $28 in July 2012 at the height of enthusiasm over its lead compound QSYMIA, Vivus (NASDAQ: VVUS) has pulled back by over 50 % as early prescription data came in far below...
Read More
category
ARNA
,
VVUS
from
Bio-Wire.Com
Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data
May 03, 2013
The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report, which briefly sent the Dow Jones Industrial Average over 15,000 for the first...
Read More
category
LNKD
,
Earnings
,
Benzinga
, and 29 more.
from
Latest Articles from Benzinga.com
Mid-Afternoon Market Update: Dow Eyeing Record Close, American Axle Rises
May 03, 2013
Toward the end of trading Friday, the Dow traded up 0.88 percent to 14,962.73 while the NASDAQ surged 1.10 percent to 3,377.74. The S&P also rose, gaining 0.99 percent to 1,613.66. Top Headline...
Read More
category
LNKD
,
Earnings
,
BCOR
, and 15 more.
from
Latest Articles from Benzinga.com
Arena Still Awaiting DEA Classification
May 03, 2013
Arena Pharmaceuticals Inc. (Nasdaq: ARNA) narrowed first quarter losses to 9 cents per share from 18 cents per share in the year ago period but the company is still waiting for the Drug Enforcement...
Read More
from
MarketMinute.com Stock News
EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List
May 03, 2013
from
ACCESSWIRE
Mid-Day Market Update: Thoratec Dips On Downbeat Profit, InvenSense Rises
May 03, 2013
Midway through trading Friday, the Dow traded up 1.04 percent to 14,985.73 while the NASDAQ surged 1.29 percent to 3,383.74. The S&P also rose, gaining 1.13 percent to 1,615.66. Top Headline Yesterday,...
Read More
category
LNKD
,
Earnings
,
BCOR
, and 16 more.
from
Latest Articles from Benzinga.com
Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report
May 03, 2013
DailyFinance.com : U.S. equity markets opened higher this morning following upward revisions from the Bureau of Labor Statistics on non-farm payrolls in February and March and a larger-than-expected...
Read More
category
apo
,
agnc
,
all
, and 15 more.
from
DailyFinance.com
Arena Pharmaceuticals Trading Lower on Heavy Volume, Inline With Overall Trend (ARNA)
May 03, 2013
from
Comtex SmarTrend® News Briefs
Arena Pharmaceuticals Crosses Below its 10-day MA (ARNA)
May 03, 2013
from
Comtex SmarTrend® News Briefs
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.